Sellas Life Sciences Group Inc
F:RXK3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
Ipsos SA
PAR:IPS
|
FR |
|
GSK plc
F:GS70
|
UK |
|
V
|
Vivendi SE
MIL:VIV
|
FR |
|
T
|
Tejon Ranch Co
F:2TJ
|
US |
|
V
|
Vivendi SE
DUS:VVU
|
FR |
|
Lument Finance Trust Inc
F:70X
|
US |
|
Daetwyler Holding AG
OTC:DATWY
|
CH |
|
Red River Bancshares Inc
F:7RR
|
US |
|
S
|
Skechers USA Inc
F:SKAA
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
B
|
Borgwarner Inc
LSE:0HOU
|
US |
|
S
|
Standard Lithium Ltd
LSE:0VIK
|
CA |
|
Vivendi SE
OTC:VIVEF
|
FR |
Bankruptcy Probability
Sellas Life Sciences Group Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sellas Life Sciences Group Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sellas Life Sciences Group Inc
NASDAQ:SLS
|
1.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sellas Life Sciences Group Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sellas Life Sciences Group Inc has no debt.
You can find a full breakdown on its Balance Sheet.
